While a non-contrast Coronary Artery Calcium (CAC) scan effectively measures hard, calcified plaque (Agatston score), it is completely blind to non-calcified, lipid-rich "soft" plaque - the very subtype responsible for the majority of acute myocardial infarctions. Contrast-enhanced Coronary Computed Tomography Angiography (CCTA) paired with AI-Quantitative Plaque Analysis (Cleerly AI) visualizes the entire vessel wall, quantifying total plaque volume (mm³), low-attenuation necrotic cores (< 30 HU), and positive remodeling.
For decades, the standard non-invasive imaging test recommended to evaluate heart attack risk has been the Coronary Artery Calcium (CAC) scan.
Patients who receive a "CAC Score of 0" are frequently told by their physicians that they have clean arteries and a 5-to-10-year "warranty period" with zero cardiovascular risk.
In modern preventive cardiology and cardiovascular computed tomography, this interpretation is recognized as dangerously incomplete: calcification is a late-stage healing response, not the initial lesion of coronary disease.
Why can a patient with a CAC score of 0 suffer a fatal heart attack from non-calcified soft plaque, how does contrast CCTA visualize the full arterial wall, and how is AI-quantitative plaque analysis (Cleerly) changing prevention?
1. The Coronary Artery Calcium (CAC) Scan: Strengths & Blind Spots#
A CAC scan is a fast, non-contrast, ECG-gated low-dose CT scan that quantifies dense hydroxyapatite mineral deposits in the coronary arteries using the Agatston Scoring System:
[THE AGATSTON CAC SCORING TIERS]
• Score 0: No identifiable calcification (Low short-term risk).
• Score 1–99: Mild calcification (Early coronary atherosclerosis).
• Score 100–399: Moderate calcified plaque burden (Elevated risk; mandates statin/ApoB therapy).
• Score ≥ 400: Severe calcification (> 90th percentile risk; high annual event rate).
The Fatal Flaw of CAC Scoring#
[THE TIMELINE OF ATHEROSCLEROSIS PROGRESSION]
Year 0 to 15: Subendothelial ApoB accumulation ──► Fatty Streak ──► SOFT LIPID PLAQUE
│ (CAC SCORE = 0)
Year 15 to 30: Inflammatory macrophage death ──► Necrotic Core ───────┤ (CAC SCORE = 0)
│ (COMPLETELY INVISIBLE!)
Year 30+: Late-stage osteogenic healing ──► DENSE CALCIFICATION ─► (CAC SCORE > 100)
- Calcification Is the Scar: Calcium deposition is the body's attempt to wall off and stabilize inflamed, necrotic lipid plaque.
- The Zero-Score Danger: Up to 10% to 15% of patients presenting with acute ST-elevation myocardial infarction (STEMI) have a CAC score of exactly 0. Their fatal events were triggered by the rupture of young, inflamed, non-calcified soft plaques that a standard CAC scan cannot detect.
2. Coronary Computed Tomography Angiography (CCTA)#
Unlike a simple calcium scan, CCTA utilizes intravenous iodinated contrast material and sub-millimeter multidetector CT scanners (often 256 to 640 slices) to visualize:
- The Coronary Lumen (detecting stenosis or narrowing).
- The Vessel Wall Thickness (detecting early plaque that expands outward without narrowing the lumen).
- The Plaque Tissue Composition based on X-ray attenuation measured in Hounsfield Units (HU).
[CCTA PLAQUE TISSUE CHARACTERIZATION]
Hounsfield Units (HU)
+1000 ── [CALCIFIED PLAQUE] (> 350 HU)
+500 ── - Dense, stable calcium shell.
+350 ──
[FIBROUS PLAQUE] (131 to 350 HU)
+130 ── - Collagen-rich matrix.
+30 ── [FIBROFATTY PLAQUE] (31 to 130 HU)
0 ── [LOW-ATTENUATION / SOFT PLAQUE] (< 30 HU)
- LIPID-RICH NECROTIC CORE.
- THIN-CAP FIBROATHEROMA (TCFA).
- HIGHEST RUPTURE VULNERABILITY!
3. High-Risk Plaque Features: The "Vulnerable Plaque"#
CCTA allows cardiologists to identify the specific anatomical features of plaques that are at high risk of sudden rupture:
| High-Risk Plaque Feature | Microscopic / Imaging Finding | Clinical Implication & Pathophysiology |
|---|---|---|
| Low-Attenuation Plaque (LAP) | Plaque core with CT density < 30 Hounsfield Units. | Represents a large necrotic lipid pool; strongest single imaging predictor of fatal myocardial infarction in the SCOT-HEART trial. |
| Positive Arterial Remodeling | Remodeling Index > 1.1 (outer vessel diameter expands outward). | The plaque grows outward into the adventitia, preserving lumen diameter (silent massive plaque that produces normal stress tests). |
| Napkin-Ring Sign | Central low attenuation surrounded by a thin rim of higher attenuation. | Classic hallmark of a Thin-Cap Fibroatheroma (TCFA) with a necrotic core separated from the bloodstream by only a fragile fibrous cap. |
| Spotty Microcalcifications | Tiny punctate calcium flecks (< 3 mm) within non-calcified plaque. | Signals active, unhealed macrophage-mediated inflammatory calcification. |
4. The AI-Quantitative Revolution: Cleerly AI & Plaque Volume#
For decades, cardiology defined disease severity by "percent luminal stenosis" (e.g., a "70% blockage").
Landmark trials have proven that most fatal heart attacks occur in arteries with < 50% stenosis that suddenly rupture.
Modern AI platforms (such as Cleerly AI) use deep-learning neural networks to perform automated voxel-by-voxel segmentation across the entire coronary tree:
[AI-QUANTITATIVE CORONARY ANGIOGRAPHY (AI-QCT) OUTPUT]
│
┌─────────────────────────────┼─────────────────────────────┐
▼ ▼ ▼
[Total Plaque Volume (TPV)] [Non-Calcified Volume (NCPV)] [Low-Density Volume (LD-NCPV)]
Total disease burden in mm³. Active, treatable lipid mass. Highly unstable necrotic core.
- The Paradigm Shift: Moving from asking "Is there a flow-limiting blockage?" to "What is the total biological volume and composition of atherosclerotic plaque inside the artery wall?"
- Tracking Plaque Regression: With aggressive ApoB lowering (< 40–50 mg/dL), repeat CCTA scans analyzed with AI quantitatively demonstrate the shrinkage of Low-Density Non-Calcified Plaque and the stabilization of the fibrous cap.
CCTA vs. CAC Scan: Master Comparison Table#
| Parameter | Coronary Artery Calcium (CAC) Scan | Contrast Coronary CT Angiography (CCTA) |
|---|---|---|
| Primary Target | Dense, hard calcified mineral only. | Full spectrum: Soft plaque, fibrous plaque, calcified plaque, and vessel lumen. |
| IV Contrast Required | No (Non-contrast scan). | Yes (Iodinated IV contrast via peripheral line). |
| Soft Plaque Detection | 0% (Completely Invisible). | 100% (High-resolution tissue density mapping). |
| Radiation Dose | ~0.5 to 1.0 mSv. | ~1.0 to 3.0 mSv (modern low-dose protocols). |
| Ideal Clinical Candidate | Asymptomatic adults seeking a quick, low-cost baseline screening. | High-risk individuals, family history of early heart attacks, elevated ApoB/Lp(a), or anyone wanting definitive soft plaque characterization. |
A nuclear stress test or treadmill EKG only becomes abnormal when a plaque blocks more than 70% of the artery lumen. Because vulnerable soft plaques expand outward into the vessel wall (positive remodeling), they are completely missed by standard stress tests until the day they rupture.
To explore blood biomarkers of active arterial inflammation and plaque instability, read Vascular Endothelial Inflammation: PLAC (Lp-PLA2), MPO & hs-CRP.
Scientific References & Clinical Practice Guidelines#
- SCOT-HEART Investigators. Coronary CT Angiography and 5-Year Risk of Myocardial Infarction. N Engl J Med. 2018;379(10):924-933. doi:10.1056/NEJMoa1805971.
- Mortensen MB, Dzaye O, Steffensen FH, et al. Impact of Plaque Burden Versus Stenosis on New-Onset Cardiovascular Events in Patients with Coronary Atherosclerosis. J Am Coll Cardiol. 2020;76(24):2803-2813. doi:10.1016/j.jacc.2020.10.021.
- Williams MC, Moss AJ, Dweck M, et al. Adverse Plaque Characteristics on Coronary CT Angiography: High-Risk Features for Myocardial Infarction. J Am Coll Cardiol. 2019;73(3):291-301. doi:10.1016/j.jacc.2018.10.066.
- Budoff MJ, Mayrhofer T, Ferencik M, et al. Prognostic Value of Coronary Artery Calcium in the PROMISE Study of Suspected CAD. Circulation. 2017;136(21):1993-2005. doi:10.1161/CIRCULATIONAHA.117.030578.
- Gulati M, Levy PD, Mukherjee D, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain. J Am Coll Cardiol. 2021;78(22):e187-e259. doi:10.1016/j.jacc.2021.09.003.
Track Your Imaging & Plaque Reports with Meridian#
Monitoring your laboratory blood biomarkers over time gives you objective validation that your diet, exercise, and lifestyle habits are keeping your metabolic health and glucose tolerance in optimal ranges.
Meridian is an offline personal health vault for iPhone designed to give you complete ownership of your medical diagnostic data.
- Instant Lab Report Extraction: Take a photo or upload a PDF of your Coronary Artery Calcium (Agatston score) reports, CCTA imaging summaries, Cleerly AI plaque volume metrics, and ApoB blood panels from Quest, Labcorp, or your imaging clinic. Meridian extracts all measurements on-device using Apple VisionKit.
- Longitudinal Plaque Burden Tracking: Keep all your past scan dates, plaque volume trajectories ($mm^3$), and physician cardiology consultations organized in one place with total privacy.
- 100% On-Device & Private: Protected by hardware AES-256 encryption and FaceID. Zero cloud servers. Zero data tracking.
Take control of your cardiovascular longevity and medical privacy today. Download Meridian on the App Store and keep your diagnostic records organized, private, and secure.